Rani Therapeutics Holdings (RANI) Retained Earnings (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Retained Earnings came in at -$8000.0 in Q1 2026, down 500.0% year-on-year from $2000.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$132.6 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Retained Earnings (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at -$8000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings fell 500.0% year-over-year to -$8000.0 in Q1 2026; TTM through Mar 2026 was -$8000.0, a 500.0% decrease from a year earlier, with the FY2025 full-year figure at -$132.6 million, down 226.4% from the prior year.
- Retained Earnings improved to -$8000.0 in Q1 2026 per RANI's latest filing, from -$132.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $104.9 million in Q4 2024 and bottomed at -$132.6 million in Q4 2025.
- The 5-year median for Retained Earnings is -$8000.0 (2026), against an average of $8.7 million.
- Biggest YoY gain for Retained Earnings was 236848.78% in 2024; the steepest drop was 138276.19% in 2024.
- Year by year, Retained Earnings stood at $75.8 million in 2022, then increased by 13.08% to $85.8 million in 2023, then advanced by 22.3% to $104.9 million in 2024, then slumped by 226.4% to -$132.6 million in 2025, then soared by 99.99% to -$8000.0 in 2026.
- Per Business Quant, the three latest RANI Retained Earnings figures stand at -$8000.0 (Q1 2026), -$132.6 million (Q4 2025), and $3000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Dec 31, 2025 | -132.58 Mn |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 104.89 Mn |
| Sep 30, 2024 | 97.07 Mn |
| Jun 30, 2024 | -87.18 Mn |
| Mar 31, 2024 | 87.78 Mn |
| Dec 31, 2023 | 85.76 Mn |
| Sep 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -63,000.00 |
| Mar 31, 2023 | -47.30 Mn |
| Dec 31, 2022 | 75.84 Mn |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -22.18 Mn |
| Mar 31, 2022 | -14.60 Mn |
| Dec 31, 2021 | -8.33 Mn |
| Sep 30, 2021 | 54.50 Mn |
| Jun 30, 2021 | -125.09 Mn |